Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Comment by thesheeton Jan 24, 2020 9:14am
92 Views
Post# 30593422

RE:RE:RE:Irrational Euphoria

RE:RE:RE:Irrational EuphoriaI got in at 48 cents cdn.

what got me at the time was that there was good progression on the drug testing yet the stock kept going down...

Also, I'm glad they did financing at a higher stock price, it's better than having to do it at 48 cents. They had a non dilutive financing in nov and still have a low share count at 28 million shares.

Those who haven't been here for long, some really big names, people that know what they are doing, got into this company a few years ago. This is cutting edge stuff and was enabled by Rob McEwen through his stem cell center in Toronto.
<< Previous
Bullboard Posts
Next >>